share_log

4: Statement of changes in beneficial ownership of securities-Director Rice Derica W

SEC ·  Jul 3 05:26

Summary by Futu AI

Bristol-Myers Squibb (BMY) has reported a transaction involving Derica W. Rice, a key figure at the company. The transaction took place on June 30, 2024. However, the details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. The address provided for Rice is associated with the company's headquarters in Princeton, NJ. The relationship of Rice to the issuer was not specified in the announcement.
Bristol-Myers Squibb (BMY) has reported a transaction involving Derica W. Rice, a key figure at the company. The transaction took place on June 30, 2024. However, the details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. The address provided for Rice is associated with the company's headquarters in Princeton, NJ. The relationship of Rice to the issuer was not specified in the announcement.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.